email article
Lung cancer diagnoses declined and outcomes deteriorated during the first 6 months of 2020, coinciding with the COVID-19 pandemic, according to a retrospective cohort study from Spain.
The number of new lung cancer cases decreased by 38% from January to June 2020 as compared with the same period a year earlier. The 30-day mortality almost doubled, and median overall survival (OS) decreased by more than a month. Lung cancer diagnosis is being affected during COVID, Roxana Reyes, MD, of Hospital Clinic de Barcelona, said during the World Conference on Lung Cancer (WCLC) virtual congress. In non-small cell lung cancer [NSCLC], we have noticed more symptomatic and more severe cases diagnosed during COVID. We observed poor outcomes, with an elevated 30-day mortality rate.
Researchers examine the connection between lung cancer and COVID-19
On February 27, 2020, the flagship journal of the International Association for the Study of Lung Cancer, the
Journal of Thoracic Oncology, published a case study that described two patients from Wuhan, China who recently underwent lung lobectomies for adenocarcinoma and were retrospectively found to have had COVID-19 at the time of surgery.
Eleven months later, the lung cancer research community gathered virtually at the IASLC 2020 World Conference on Lung Cancer Singapore to share a number of research findings examining the intersection of COVID-19 and lung cancer. Researchers from a variety of countries participated in a press briefing to examine the connection between lung cancer and COVID-19.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Researchers Probe New Territory in Treating Patients with Lung Cancer during COVID-19 Pandemic
International Association for the Study of Lung CancerJanuary 29, 2021 GMT
Press Briefing with International Researchers Explores this Question at IASLC 2020 World Conference on Lung Cancer Singapore
To view a recording of the press briefing, visit:https://vimeo.com/506248459/caa7346336
SINGAPORE, Jan. 29, 2021 (GLOBE NEWSWIRE) On February 27, 2020, the flagship journal of the International Association for the Study of Lung Cancer, the
Journal of Thoracic Oncology, published a case study that described two patients from Wuhan, China who recently underwent lung lobectomies for adenocarcinoma and were retrospectively found to have had COVID-19 at the time of surgery.
Researchers Probe New Territory in Treating Patients with Lung Cancer during COVID-19 Pandemic
Press Briefing with International Researchers Explores this Question at IASLC 2020 World Conference on Lung Cancer Singapore
To view a recording of the press briefing, visit: https://vimeo.com/506248459/caa7346336
SINGAPORE, Jan. 29, 2021 (GLOBE NEWSWIRE) On February 27, 2020, the flagship journal of the International Association for the Study of Lung Cancer, the
Journal of Thoracic Oncology, published a case study that described two patients from Wuhan, China who recently underwent lung lobectomies for adenocarcinoma and were retrospectively found to have had COVID-19 at the time of surgery.
Eleven months later, the lung cancer research community gathered virtually at the IASLC 2020 World Conference on Lung Cancer Singapore to share a number of research findings examining the intersection of COVID-19 and lung cancer. Researchers from a variety of countries participated in a
E-Mail
(Singapore January 29, 2021 11:00 p.m. SPT/10:00 a.m. EST) On February 27, 2020, the flagship journal of the International Association for the Study of Lung Cancer, the
Journal of Thoracic Oncology, published a case study that described two patients from Wuhan, China who recently underwent lung lobectomies for adenocarcinoma and were retrospectively found to have had COVID-19 at the time of surgery.
Eleven months later, the lung cancer research community gathered virtually at the IASLC 2020 World Conference on Lung Cancer Singapore to share a number of research findings examining the intersection of COVID-19 and lung cancer. Researchers from a variety of countries participated in a press briefing to examine the connection between lung cancer and COVID-19.